Friday , March 29 2024
Home / Mike Norman Economics / GSK to collaborate with Chinese biotech on COVID-19 vaccine

GSK to collaborate with Chinese biotech on COVID-19 vaccine

Summary:
GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.GSK to collaborate with Chinese biotech on COVID-19 vaccine

Topics:
Mike Norman considers the following as important:

This could be interesting, too:

Mike Norman writes Rinse and repeat–Truss chaos–the new benchmark — Bill Mitchell

Lars Pålsson Syll writes The man who never wavered — Alan Bates

Joel Eissenberg writes You can’t fool Mother Nature

Bill Haskell writes Grades and learning

GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.

GSK to collaborate with Chinese biotech on COVID-19 vaccine

Mike Norman
Mike Norman is an economist and veteran trader whose career has spanned over 30 years on Wall Street. He is a former member and trader on the CME, NYMEX, COMEX and NYFE and he managed money for one of the largest hedge funds and ran a prop trading desk for Credit Suisse.

Leave a Reply

Your email address will not be published. Required fields are marked *